Treatment will be given to the patients at Contoso center.patients must have histologically confirmed NHL or HL (defined by WHO criteria). patients with chronic lymphocytic leukemia (cll) and small lymphocytic lymphoma (sll) are eligible. in addition patients with NHL other than diffuse large b cell lymphomas (dlbcl) must have received at least 2 prior therapies. patients diagnosed with HL will be eligible if there is no available standard therapy.